MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nmd.2022.10.007

Медицинская библиотека · Neuromuscular disorders : NMD · 2022

CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model.

Morera Cristina, Kim Jihee, Paredes-Redondo Amaia, Nobles Muriel, Rybin Denis, Moccia Robert, Kowala Anna, Meng Jinhong, Garren Seth, Liu Pentao, Morgan Jennifer E, Muntoni Francesco, Christoforou Nicolas, Owens Jane, Tinker Andrew, Lin Yung-Yao

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Mutations in the dystrophin gene cause the most common and currently incurable Duchenne muscular dystrophy (DMD) characterized by progressive muscle wasting. Although abnormal Ca2+ handling is a pathological feature of DMD, mechanisms underlying defective Ca2+ homeostasis remain unclear. Here we generate a novel DMD patient-derived pluripotent stem cell (PSC) model of skeletal muscle with an isogenic control using clustered regularly interspaced short palindromic repeat (CRISPR)-mediated precise gene correction. Transcriptome analysis identifies dysregulated gene sets in the absence of dystrophin, including genes involved in Ca2+ handling, excitation-contraction coupling and muscle contraction. Specifically, analysis of intracellular Ca2+ transients and mathematical modeling of Ca2+ dynamics reveal significantly reduced cytosolic Ca2+ clearance rates in DMD-PSC derived myotubes. Pharmacological assays demonstrate Ca2+ flux in myotubes is determined by both intracellular and extracellular sources. DMD-PSC derived myotubes display significantly reduced velocity of contractility. Compared with a non-isogenic wildtype PSC line, these pathophysiological defects could be rescued by CRISPR-mediated precise gene correction. Our study provides new insights into abnormal Ca2+ homeostasis in DMD and suggests that Ca2+ signaling pathways amenable to pharmacological modulation are potential therapeutic targets. Importantly, we have established a human physiology-relevant in vitro model enabling rapid pre-clinical testing of potential therapies for DMD.

Для цитирования: Morera Cristina, Kim Jihee, Paredes-Redondo Amaia, Nobles Muriel, Rybin Denis, Moccia Robert, Kowala Anna, Meng Jinhong, Garren Seth, Liu Pentao, Morgan Jennifer E, Muntoni Francesco, Christoforou Nicolas, Owens Jane, Tinker Andrew, Lin Yung-Yao. CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell model.. Neuromuscular disorders : NMD. 2022. DOI: 10.1016/j.nmd.2022.10.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.